Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

NeuroOp Guru

The Residency Report

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

IOL Advances

Imaging

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Interventional Glaucoma

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

News

All News

Contributors

Money Matters

Media

All Videos

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

Articles

Ashvattha Therapeutics reveals promising phase 2 results for migaldendranib, showcasing significant improvements in retinal disease treatment and reduced injection burden.

Ashvattha reports positive phase 2 data for migaldendranib in retinal diseases

Financing will fund phase 1b trials evaluating its lead candidate, THN391, for the treatment of Alzheimer’s Disease and Diabetic Macular Edema (DME).

Therini Bio raises $39 million in a Series A extension financing

SYL1801 is an investigational siRNA therapy administered via eye drops, rather than intravitreal injection, to treat nAMD.

Sylentis releases topline results from phase 2a of SYL1801

Videos

At ARVO 2025, in Salt Lake City, Utah, Ferhina Ali, MD, MPH, talked about her presentation on the early real-world use of aflibercept 8 mg in treatment-naive patients with neovascular age-related macular degeneration

ARVO 2025: Aflibercept 8mg in treatment-naive AMD

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

About

Advertise

Privacy

Editorial Info

Editorial Board

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times - Ophthalmology news, articles, and events

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Glaucoma

View

Expanding the Range of Vision with Innovative Monofocal Intraocular Lenses

Dean McGee Eye Institute

An ophthalmologist presents a case of a 75-year-old patient who was dissatisfied with previous intraocular lenses but achieved satisfactory vision with a monofocal plus IOL.

A Case of IOL Exchange in a Patient Unhappy with their Previous Advanced Technology IOLs

Kamran Riaz, MD, presents an overview of enhanced monofocal IOLs and discusses special cases where they could be considered in addition to conventional cataract surgery.

Kamran Riaz, MD, provides an overview of current monofocal intraocular lens options, focusing on the most popular choices.

Overview of Current Monofocal plus IOL Options

An expert on ophthalmic conditions presents the case of a patient with Fuchs dystrophy and cataracts in both eyes who inquired about intraocular lenses.

A Case of Triple DMEK with Monofocal Plus IOL

Kamran Riaz, MD, reviews a cataract surgery case where the patient was fitted with different IOLs in each eye.

Mixing and Matching Monofocal Plus IOLs with Other Advanced Technology IOLs

SAP Partner

A Case of IOL Exchange in a Patient Unhappy with their Previous Advanced Technology IOLs

EP: 1.Overview of Current Monofocal plus IOL Options

EP: 2.A Case of IOL Exchange in a Patient Unhappy with their Previous Advanced Technology IOLs

EP: 3.A Case of Triple DMEK with Monofocal Plus IOL

EP: 4.Mixing and Matching Monofocal Plus IOLs with Other Advanced Technology IOLs

Newsletter